Literature DB >> 33450210

Mitochondrial NAD+ Controls Nuclear ARTD1-Induced ADP-Ribosylation.

Ann-Katrin Hopp1, Federico Teloni1, Lavinia Bisceglie1, Corentin Gondrand2, Fabio Raith3, Kathrin Nowak1, Lukas Muskalla4, Anna Howald5, Patrick G A Pedrioli6, Kai Johnsson2, Matthias Altmeyer5, Deena M Leslie Pedrioli5, Michael O Hottiger7.   

Abstract

In addition to its role as an electron transporter, mitochondrial nicotinamide adenine dinucleotide (NAD+) is an important co-factor for enzymatic reactions, including ADP-ribosylation. Although mitochondria harbor the most intra-cellular NAD+, mitochondrial ADP-ribosylation remains poorly understood. Here we provide evidence for mitochondrial ADP-ribosylation, which was identified using various methodologies including immunofluorescence, western blot, and mass spectrometry. We show that mitochondrial ADP-ribosylation reversibly increases in response to respiratory chain inhibition. Conversely, H2O2-induced oxidative stress reciprocally induces nuclear and reduces mitochondrial ADP-ribosylation. Elevated mitochondrial ADP-ribosylation, in turn, dampens H2O2-triggered nuclear ADP-ribosylation and increases MMS-induced ARTD1 chromatin retention. Interestingly, co-treatment of cells with the mitochondrial uncoupler FCCP decreases PARP inhibitor efficacy. Together, our results suggest that mitochondrial ADP-ribosylation is a dynamic cellular process that impacts nuclear ADP-ribosylation and provide evidence for a NAD+-mediated mitochondrial-nuclear crosstalk.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADP-ribosylation; ARTD1; DNA damage; NAD; PARP inhibitors; PARP-inhibitor; PARP1; mito-nuclear crosstalk; mitochondria; mitochondrial ADP-ribosylation

Mesh:

Substances:

Year:  2021        PMID: 33450210      PMCID: PMC7837215          DOI: 10.1016/j.molcel.2020.12.034

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  71 in total

1.  Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

Authors:  Kathryn F Mills; Shohei Yoshida; Liana R Stein; Alessia Grozio; Shunsuke Kubota; Yo Sasaki; Philip Redpath; Marie E Migaud; Rajendra S Apte; Koji Uchida; Jun Yoshino; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

2.  A Bacterial Effector Reveals the V-ATPase-ATG16L1 Axis that Initiates Xenophagy.

Authors:  Yue Xu; Ping Zhou; Sen Cheng; Qiuhe Lu; Kathrin Nowak; Ann-Katrin Hopp; Lin Li; Xuyan Shi; Zhiwei Zhou; Wenqing Gao; Da Li; Huabin He; Xiaoyun Liu; Jingjin Ding; Michael O Hottiger; Feng Shao
Journal:  Cell       Date:  2019-07-18       Impact factor: 41.582

3.  Systems-wide Analysis of Serine ADP-Ribosylation Reveals Widespread Occurrence and Site-Specific Overlap with Phosphorylation.

Authors:  Sara C Larsen; Ivo A Hendriks; David Lyon; Lars J Jensen; Michael L Nielsen
Journal:  Cell Rep       Date:  2018-08-28       Impact factor: 9.423

4.  Absolute Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial Metabolism.

Authors:  Walter W Chen; Elizaveta Freinkman; Tim Wang; Kıvanç Birsoy; David M Sabatini
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

5.  Oligomycin frames a common drug-binding site in the ATP synthase.

Authors:  Jindrich Symersky; Daniel Osowski; D Eric Walters; David M Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

6.  2016 update of the PRIDE database and its related tools.

Authors:  Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

7.  MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins.

Authors:  Sarah E Calvo; Karl R Clauser; Vamsi K Mootha
Journal:  Nucleic Acids Res       Date:  2015-10-07       Impact factor: 16.971

8.  Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin.

Authors:  Hana Hanzlikova; William Gittens; Katerina Krejcikova; Zhihong Zeng; Keith W Caldecott
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

9.  Nicotinamide adenine dinucleotide is transported into mammalian mitochondria.

Authors:  Antonio Davila; Ling Liu; Karthikeyani Chellappa; Philip Redpath; Eiko Nakamaru-Ogiso; Lauren M Paolella; Zhigang Zhang; Marie E Migaud; Joshua D Rabinowitz; Joseph A Baur
Journal:  Elife       Date:  2018-06-12       Impact factor: 8.140

View more
  6 in total

Review 1.  Research Progress on Mono-ADP-Ribosyltransferases in Human Cell Biology.

Authors:  Yujie Gan; Huanhuan Sha; Renrui Zou; Miao Xu; Yuan Zhang; Jifeng Feng; Jianzhong Wu
Journal:  Front Cell Dev Biol       Date:  2022-05-16

Review 2.  Fueling genome maintenance: On the versatile roles of NAD+ in preserving DNA integrity.

Authors:  Joanna A Ruszkiewicz; Alexander Bürkle; Aswin Mangerich
Journal:  J Biol Chem       Date:  2022-05-17       Impact factor: 5.486

Review 3.  The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions.

Authors:  Carlo Fortunato; Francesca Mazzola; Nadia Raffaelli
Journal:  IUBMB Life       Date:  2021-12-05       Impact factor: 4.709

Review 4.  Maintenance of NAD+ Homeostasis in Skeletal Muscle during Aging and Exercise.

Authors:  Li Li Ji; Dongwook Yeo
Journal:  Cells       Date:  2022-02-17       Impact factor: 6.600

5.  Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers.

Authors:  Fabio Aimi; Holger Moch; Peter Schraml; Michael O Hottiger
Journal:  Mod Pathol       Date:  2021-03-19       Impact factor: 7.842

Review 6.  Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.

Authors:  Ann-Katrin Hopp; Michael O Hottiger
Journal:  Cells       Date:  2021-03-19       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.